Oxford brings rare venture capital-backed ABS
Venture capital firm Oxford Finance is issuing a $312.8m securitization backed by loans made to life sciences and healthcare companies, the largest deal from the issuer and its fastest return to market since issuing its previous deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: